细胞凋亡抑制蛋白cIAP 与卵巢癌耐药性的研究进展

卵巢恶性肿瘤是女性生殖系统三大恶性肿瘤之一,其发病率在女性生殖系统肿瘤中占第三位,而死亡率却高居首位。目前对于晚期卵巢癌(Ⅲ或Ⅳ期)多倾向于用新辅助化疗+肿瘤细胞减灭术+术后周期性化疗的治疗方法。但是,尽管多数患者在最初对化疗药物较敏感,但仍有60%~80%最终死于卵巢癌,这些患者大部分都对化疗药物产生了耐药性,在更换新的化疗方案初期是有效的,但最终仍会耐药。近年来,有关细胞凋亡抑制蛋白(cIAP,cellular inhibitors of apoptosis proteins)在卵巢癌复发耐药中的作用机制的研究越来越受到重视。研究证实,cIAP在耐药肿瘤细胞中呈高表达,并与多种因子共同参与形成了上皮性卵巢癌的耐药机制,抑制了化疗药物引起的肿瘤细胞的凋亡。这些发现为攻克卵巢癌的耐药机制提供了重要线索,也为卵巢癌化疗药物的应用指出了新的方向。     

TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-κB signaling

B-cell-activating factor of the TNF family (BAFF) is a critical factor for B-cell survival and maturation through non-canonical nuclear factor κB (NF-κB) pathway, a NF-κB inducing kinase (NIK)-dependent pathway for the processing of NF-κB2 p100 to generate p52. While BAFF acts primarily through BAFF receptor (BAFF-R), the transmembrane activator and CAML interactor (TACI), the other receptor for BAFF, is thought to serve as a negative regulator for B-cell responses. However, how TACI regulates NF-κB2 activity is largely unknown. In this study, we showed that constitutive activation of TACI signaling suppressed BAFF-R–mediated NF-κB2 p100 processing with the up-regulation of cellular inhibitors of apoptosis 1 (cIAP1) and TNF receptor associated factor (TRAF)-associated NF-κB activator (TANK). The ubiquitination of NIK by cIAP1 was inhibited by the expression of TRAF2 with physical binding to cIAP1. TANK deficiency by small interfering RNA (siRNA) impaired TACI-dependent inhibition of NF-κB2 p100 processing. TANK also inhibited TRAF2-mediated cIAP1 inactivation. Moreover, the recruitment of TRAF2 to TACI induced the ubiquitination of NIK. Taken together, the regulation of NIK by TACI through the interaction of TANK/TRAF2/cIAP1 plays a pivotal role in the suppression of non-canonical NF-κB signaling.     

TXA2/PGI2与心血管疾病

血栓素(Thromboxane,TXA2)和前列环素(Prostacyclin,PGI2)均为花生四烯酸的代谢物,是前列腺素(Prostaglandins,PGs)中生物活性最强的一对。在正常情况下,二者在体内保持一定的平衡,相互拮抗、相互协调,共同维持血液循环畅通,与心血管疾病关系密切。本文即就其生物特性及与心血管病的关系等进行综述,对人们全面认识TXA2/PGI2具有一定的参考价值。     

Synthesis and structural characterization of the molecular loop [cis-Mo2(N,N-di-p-anisylformamidinate)2]2(O2C-CHCCH-CO2)2

A new molecular loop composed of two quadruply bonded Mo₂(DAniF)₂ units (DAniF=N,N^′-di-p-anisylformamidinate) linked by two chiral allene-1,3-dicarboxylate anions has been prepared from the reaction of [cis-Mo₂(DAniF)₂(MeCN)₄](BF₄)₂ with the bis(tetraethylammonium) salt of allene-1,3-dicarboxylic acid. This compound, [cis-Mo₂(DAniF)₂]₂(O₂C-CHCCH-CO₂)₂ (1), has been characterized by X-ray crystallography and by ¹H NMR and UV-Vis spectroscopy. The molecule possesses a center of inversion and hence is meso. There is only weak electronic coupling between the two Mo₂ ⁴⁺ units as revealed by electrochemical measurements.     

Malt1 and cIAP2–Malt1 as effectors of NF-κB activation: Kissing cousins or distant relatives?

Malt1 is a multi-domain cytosolic signaling molecule that was originally identified as the target of recurrent translocations in a large fraction of MALT lymphomas. The product of this translocation is a chimeric protein in which the N-terminus is contributed by the apoptosis inhibitor, cIAP2, and the C-terminus is contributed by Malt1. Early studies suggested that Malt1 is an essential intermediate in antigen receptor activation of NF-κB, and that the juxtaposition of the cIAP2 N-terminus and the Malt1 C-terminus results in deregulation of Malt1 NF-κB stimulatory activity. Initial experimental data further suggested that the molecular mechanisms of Malt1- and cIAP-Malt1-mediated NF-κB activation were quite similar. However, a number of more recent studies of both Malt1 and cIAP2–Malt1 now reveal that these proteins influence NF-κB activation by multiple distinct mechanisms, several of which are non-overlapping. Currently available data suggest a revised model in which cIAP2–Malt1 induces NF-κB activation via a mechanism that depends equally on domains contributed by cIAP2 and Malt1, which confer spontaneous oligomerization activity, polyubiquitin binding, proteolytic activity, and association with and activation of TRAF2 and TRAF6 at several independent binding sites. By contrast, emerging data suggest that the wild-type Malt1 protein uniquely contributes to NF-κB activation primarily through the control of two proteolytic cleavage mechanisms. Firstly, Malt1 directly cleaves and inactivates A20, a negative regulator of the antigen receptor-to-NF-κB pathway. Secondly, Malt1 interacts with caspase-8, inducing caspase-8 cleavage of c-FLIP_L, initiating a pathway that contributes to activation of the IκB kinase (IKK) complex. Furthermore, data suggest that Malt1 plays a more limited and focused role in antigen receptor activation of NF-κB, serving to augment weak antigen signals and stimulate a defined subset of NF-κB dependent responses. Thus, the potent activation of NF-κB by cIAP2–Malt1 contrasts with the more subtle role of Malt1 in regulating specific NF-κB responses downstream of antigen receptor ligation.     

The reactions of 2-hydroxypyridine ligands with Re2Cl4(μ-dppm)2 (dppm=Ph2PCH2PPh2) that lead to 2-pyridonate complexes

2-Hydroxypyridine (Hhp), 2-hydroxynicotinic acid (HnicOH) and 6-hydroxypicolinic acid (HpicOH) react with Re₂Cl₄(μ-dppm)₂ (dppm=Ph₂PCH₂PPh₂) to afford the complexes Re₂(η²-hp)Cl₃(μ-dppm)₂ (1), Re₂(η²-HnicO)Cl₃(μ-dppm)₂ (2) and Re₂(μ-picO)₂(μ-dppm)₂ (3). The identities of 1 and 2 have been established by single-crystal X-ray structure determinations (Re-Re distances of 2.2602(3) and 2.2539(3) Å, respectively) and they are shown to have unsymmetrical structures with staggered rotational geometries and trans, cis coordination of the pair of μ-dppm ligands. The crystal of 2 that was used in the structure determination was found to be of composition 2Re₂(η²-HnicO)Cl₃(μ-dppm)₂ · Re₂Cl₆(μ-dppm)₂ · 2.906CH₂Cl₂. The structure of Re₂Cl₆(μ-dppm)₂ in this crystal is compared with structures reported in the literature for other crystals that contain this edge-sharing bioctahedral dirhenium(III) complex.     

Molecular structure of tetranuclear [{Mo2O(S2CNEt2)(η-O2CCF3)(μ-N-o-tol)2}2(μ-O)(μ-O2CCF3)2] formed upon addition of trifluoroacetic acid to syn-[MoO(μ-N-o-tol)(S2CNEt2)]2

Addition of trifluoroacetic acid to syn-[MoO(μ-N-o-tol)(S₂CNEt₂)]₂ in chloroform affords tetranuclear [{Mo₂O(S₂CNEt₂)(η¹-O₂CCF₃)(μ-N-o-tol)₂}₂(μ-O)(μ-O₂CCF₃)₂] which has been crystallographically characterised. It consists of four molybdenum(V) centres linked via bridging imido, trifluoroacetate and oxo ligands and results from replacement of a dithiocarbamate by two trifluoroacetate ligands.     

Mdm2/MdmX抑制剂

Mdm2(murine double minute 2,又称为Hdm2)和Mdm X(murine double minute X,又称为Hdm4)的异常过表达与近半数的癌症直接相关,设计靶向Mdm2/Mdm X-p53蛋白质相互作用位点抑制剂,解除Mdm2和Mdm X对p53的抑制作用有着重要的临床意义。尽管Mdm2和MdmX结构非常相似,但仅有Mdm2小分子抑制剂的筛选和设计研究较深入。对依据nutlin分子构效关系、结构生物学、组合化学多重优化等手段筛设计MdmX抑制剂的研究进展进行简述,并讨论天然产物库在筛选Mdm X/Mdm2抑制剂新型结构框架的应用前景。     

hpc2研究进展

生物个体的胚胎发育以及细胞的增殖、分化,都同时受到多种基因的严格调控,PcG基因家族就是一类重要的发育相关基因.而hPc2基因是人PcG基因家族中的一个重要成员,其编码的HPC2蛋白,不仅可以和HPH、BMI-1以及RING1等其他人类PcG蛋白结合形成HPC/HPH PcG复合体,以蛋白复合体的形式参与对homeotic基因的表达抑制,以维持机体的正常发育以及细胞的增殖和定向分化,还发现它能与其他多种蛋白质相结合,提示HPC2可能具有多种功能.因此,对hPc2的深入研究不仅有助于进一步阐明PcG基因家族的作用机理,扩展人们对基因表达调控的认识,还有助于发现PcG基因家族与其他信号转导通路的联系,更好地理解细胞信号网络系统.     

H2O2诱导Neuro-2a细胞死亡机理的研究

细胞内线粒体呼吸链过程中的电子漏和神经细胞代谢的酶类如单胺氧化酶(MAO)等可产生活性氧物质(ROS)如H2O2等.ROS对细胞有毒性作用,导致细胞死亡,在许多疾病特别是神经退行性疾病中具有重要作用.我们用H2O2诱导N-2a神经母细胞瘤细胞,利用光镜、荧光显微镜、透射电镜观察了诱导的N-2a细胞的死亡,结果表明其死亡形式不同于典型的细胞凋亡,而类似于Ⅱ型神经细胞编程性死亡,死亡细胞染色质呈团块状凝集,细胞核膜仍保持完整.DNA不降解形成ladder,且不需要caspase-3,1的活性,但是H2O2诱导的Neuro-2a细胞死亡可以被Bcl-XL抑制.我们的结果可以说明,ROS介导的细胞毒性作用是导致Ⅱ型神经细胞编程性死亡的一个原因.     

Ca2+位于H2O2上游参与H2S诱导的拟南芥气孔关闭过程

以拟南芥为材料,利用药理学实验,结合分光光度法和激光共聚焦显微技术,研究了Ca2+在硫化氢(H2S)诱导拟南芥气孔关闭过程中的作用及其与过氧化氢(H2O2)的关系。结果表明:H2S诱导气孔关闭,Ca2+螯合剂EGTA和质膜Ca2+通道阻断剂硝苯地平(Nif)能不同程度抑制H2S诱导的气孔关闭,而内质网钙泵阻断剂毒胡萝卜素(Thaps)对H2S的作用无显著影响。由此推测,Ca2+参与调节H2S诱导的拟南芥气孔关闭过程,且胞质中Ca2+来源于胞外Ca2+的内流。另外,H2S诱导拟南芥叶片NADPH氧化酶基因At RBOHD和At RBOHF以及细胞壁过氧化物酶基因At PRX34表达增强,促进叶片和保卫细胞中H2O2积累,EGTA对此起抑制作用,而外源Ca Cl2处理上调At RBOHD、At RBOHF和At PRX34的表达。表明Ca2+可能位于H2O2上游参与H2S诱导的拟南芥气孔关闭过程。     

WNK2通过抑制ERK1/2/ROS/SHP2信号通路延缓肝细胞癌的增殖和侵袭

目的 探讨WNK2对肝细胞癌(hepatocellocellua carcinoma, HCC)中ERK1/2/ROS/SHP2信号通路的影响,并探讨其在HCC细胞增殖和迁移中的作用。方法 将WNK2-mimic和sh-RNA WNK2以及相应的阴性对照转染HepG2细胞,采用BALB/c裸鼠皮下成瘤实验检测WNK2对肝细胞癌增殖能力的影响;采用Western Blot检测瘤组织中WNK2、p40、gp90、p-SHP2、p-AKT和p-ERK1/2的表达;使用SHP2抑制剂PHPS1进行处理之后,采用Western Blot检测HepG2细胞中WNK2、p40、gp90、p-SHP2、p-AKT和p-ERK1/2的表达;使用细胞划痕实验和Transwell检测HepG2细胞的迁移能力和侵袭能力;采用单克隆增殖实验和CCK-8检测HepG2细胞的增殖能力。结果 与sh-NC组相比,sh-RNA WNK2组裸鼠的瘤体体积显著增大(P<0.01);而与NC-mimic组相比,WNK2-mimic组裸鼠的瘤体体积显著减小(P<0.01);Western Blot结果显示,与sh-...     

植物细胞H2O2的信号转导途径

光、环境胁迫和植物激素ABA可以引起植物体内H₂O₂升高, 而H₂O₂作为一个较早进化出来的信号分子, 不仅在诱导氧化性光合作用中起了关键的作用, 并且可以调节诸如气孔运动、超敏反应、细胞凋亡和基因表达等许多过程. 细胞内H₂O₂浓度必须维持在一种精细平衡状态, 它一方面可以通过质膜氧化还原系统和光呼吸系统产生, 另一方面也存在完善的清除机制. H₂O₂从质外体或者产生源进入细胞, 然后进入亚细胞区域. H₂O₂可以调节信号转导蛋白, 如蛋白质磷酸化酶、转录因子、以及位于质膜或其它膜上的Ca²⁺通道. 其中, 蛋白质可逆磷酸化可启动细胞质和细胞核的下游信号转导, 通过影响转录因子而影响基因的表达; 转录因子通过氧化而激活自身或诱导其定向转运至细胞核内. 然而, H₂O₂作为信号分子的研究相对处于“年轻”阶段, 诸如细胞如何感受H₂O₂, 以及在细胞感受H₂O₂信号转导过程中哪种细胞过程是最主要的或是限速步骤, 何种基因对H₂O₂是特异和必需的等问题仍然所知甚少, 这些问题的破解依赖于功能基因组学和遗传学分析.     

森林采伐格局控制的21/2原则

森林生产力可以由独占圆推导的原则所优化 ,独占圆是以林木为圆心 ,以其邻体距离的 1/ 2为半径所画的圆。已经证明独占圆有如下 3个特性 :(1)独占圆之间不会重叠 ,最近的关系是相切 ;(2 )完全均匀分布格局的独占圆总面积与植物株数无关 ,而且是样地总面积的 2倍 ;(3)从样地上去掉一株植物 ,只会增大某些独占圆的面积 ,而不会减少其它独占圆的面积。定义均匀度 (L )为 :样地上的独占圆总面积除以完全均匀格局的相同样地上的独占圆总面积。均匀度 (L )服从分布 :L～ x2 (2 n) / 2πn,且有E(L) =1/ π=0 .318,L 的方差 D(L) =1/ nπ2 ,可见 E(L)与 n和样地面积均无关 ,L 是一个相对指标。 L 可以用于对格局类型的检验。“增面积林木”定义为 :去掉它可以增加独占圆总面积的林木。第二邻体距离大于第一邻体距离 2倍的林木就是增面积林木 ,这就是所谓 2原则。在所调查的样地上 ,随意性地将样地分成 6块 ,在每块样地上其增面积林木的比例均约为 1/ 2 ,无一例外。在随机格局的假设下 ,推导了 6块分割样地的增面积林木的期望比例 ,其值为 0 .35～ 0 .4 4。显然 ,期望值与抽样值的差异明显 ,而引起差的原因尚难以解释 ,有待进一步研究。提出了在择伐中增加林地均匀度的两条原则 :(1)独占圆面积偏小 ;(2 )增面积林     

The Toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade

The specific TLR2/1 complex activator Pam3CSK4 has been shown to provoke prominent activation and aggregation of human non-nucleated platelets. As Pam3CSK4-evoked platelet activation does not employ the major signalling pathway established in nucleated immune cells, we investigated if the TLR2/1 complex on platelets may initiate signalling pathways known to be induced by physiological agonists such as collagen via GPVI or thrombin via PARs. We found that triggering TLR2/1 complex-signalling with Pam3CSK4, in common with that induced via GPVI, and in contrast to that provoked by PARs, involves tyrosine phosphorylation of the adaptor protein LAT as well as of PLCγ2 in a src- and Syk-dependent manner. In this respect, we provide evidence that Pam3CSK4 does not cross-activate GPVI.Further, by the use of platelets from a Glanzmann's thrombasthenia patient lacking β₃, in contrast to findings in nucleated immune cells, we show that the initiation of platelet activation by Pam3CSK4 does not involve integrin β₃ signalling; whereas the latter, subsequent to intermediate TXA2 synthesis and signalling, was found to be indispensable for proper dense granule secretion and full platelet aggregation. Together, our findings reveal that triggering the TLR2/1 complex with Pam3CSK4 initiates human platelet activation by engaging tyrosine kinases of the src family and Syk, the adaptor protein LAT, as well as the key mediator PLCγ2.